Top entities: Medpace, The Schall Law Firm, Brian Schall, United States — United States Securities and Exchange Commission.

What category does this event fall under?

Regulatory — classified as class action.

What is the sentiment of coverage?

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated May 14, 2026. Coverage continues to evolve.

Regulatory class action

Medpace Securities Fraud Class Action

Q: When did this event occur?

First reported May 01, 2026; last updated May 14, 2026.

Q: What is the market impact?

Direct. The class action lawsuit against Medpace for alleged securities fraud could lead to significant financial penalties and reputational damage for Medpace, potentially impacting its stock price negatively.

Analysis based on 8 articles · First reported May 01, 2026 · Last updated May 14, 2026

Sentiment

-50

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The class action lawsuit against Medpace for alleged securities fraud could lead to significant financial penalties and reputational damage for Medpace, potentially impacting its stock price negatively. Investors who purchased Medpace securities during the specified Class Period may recover losses if the lawsuit is successful.

Pharmaceuticals Legal Services

Event Summary

The The Schall Law Firm has initiated a class action lawsuit against Medpace Holdings, Inc. for alleged violations of the Securities Exchange Act of 1934. The lawsuit claims that Medpace made false and misleading statements to the market, engaging in a scheme to artificially inflate its share price between April 22, 2025, and February 9, 2026. Investors who suffered losses during this 'Class Period' are encouraged to join the lawsuit before June 5, 2026. The The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation.

Key Actions

100 The Schall Law Firm reminded investors of lawsuit Medpace

Entities Involved

stock

Medpace

Medpace is the target of a class action lawsuit for allegedly making false and misleading statements to artificially inflate its share price, leading to investor losses.

Importance 100 Sentiment -70

priv

The Schall Law Firm

The The Schall Law Firm is initiating and representing investors in the class action lawsuit against Medpace.

Importance 80 Sentiment 20

per

Brian Schall

Brian Schall is an attorney at the The Schall Law Firm, encouraging investors to participate in the lawsuit.

Importance 60 Sentiment 10

govactor

United States — United States Securities and Exchange Commission

The lawsuit cites violations of rules promulgated by the United States — United States Securities and Exchange Commission.

Importance 20 Sentiment 0

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard